Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA)‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
Title (eng)
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA)‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
Author
Bernardo Sousa‐Pinto
MEDCIDS—Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine University of Porto Porto Portugal
Holger J. Schünemann
Alkis Togias
Boleslaw Samolinski
Arunas Valiulis
Sian Williams
Anna Bedbrook
Wienczyslawa Czarlewski
Mark S. Dykewicz
Cristina Jacomelli
Lucas Leemann
Yuliia Palamarchuk
Ana Margarida Pereira
Maria Teresa Ventura
Juan Jose Yepes‐Nuñez
Giorgio Ciprandi
Bilun Gemicioglu
Brigita Gradauskiene
Piotr Kuna
Violeta Kvedariene
Désirée E. Larenas‐Linnemann
Amir H. A. Latiff
Yousser Mohammad
Ken Ohta
Padukudru A. Mahesh
Frederico S. Regateiro
Nicolas Roche
Mikhail Sofiev
Luís Taborda‐Barata
Charlotte Suppli Ulrik
Marylin Valentin Rostan
Giovanni Viegi
Josep M. Antó
Juan Carlos Ivancevich
Nikolai Khaltaev
Baharudin Abdullah
Mona Al‐Ahmad
Karl‐C Bergmann
Michael S. Blaiss
Fulvio Braido
Paulo Camargos
Pedro Carreiro‐Martins
Thomas Casale
George Christoff
Ieva Cirule
Elisio M. Costa
Philippe Devillier
Dejan Dokic
Elham Hossny
Carla Irani
Zhanat Ispayeva
Kaja Julge
Igor Kaidashev
Kazi S. Bennoor
Helga Kraxner
Marek Kulus
Maciej Kupczyk
Stefania La Grutta
Neven Miculinic
Lan Le Thi Tuyet
Michael Makris
Branislava Milenkovic
Stephen Montefort
André Moreira
Joaquim Mullol
Alla Nakonechna
Hugo E. Neffen
Dieudonné Nyembue
Ismail Ogulur
Yoshitaka Okamoto
Heidi Olze
Constantinos Pitsios
Todor A. Popov
Francesca Puggioni
Santiago Quirce
Agné Ramonaité
Marysia Recto
Menachem Rottem
Marianella Salapatas
Joaquin Sastre
Nicola Scichilone
Juan Carlos Sisul
Dirceu Solé
Manuel E. Soto‐Martinez
Milan Sova
Pongsakorn Tantilipikorn
Ana Todo‐Bom
Ioanna Tsiligianni
Marilyn Urrutia‐Pereira
Erkka Valovirta
Eric Van Ganse
Tuula Vasankari
Dana Wallace
Osman M. Yusuf
Mihaela Zidarn
Sara Gil‐Mata
Manuel Marques‐Cruz
Bassam Mahboub
Ignacio J. Ansotegui
Antonino Romano
Bruno Barreto
Bianca Beghe
Jacques Bouchard
Luisa Brussino
Roland Buhl
Mario Calvo‐Gil
Victoria Cardona Dahl
José Antonio Castillo Vizuete
Denis Charpin
Niels H. Chavannes
Marta Chełmińska
Lei Cheng
Ekaterine Chkhartishvili
Herberto Jose Chong‐Neto
Deepa Choudhury
Derek Chu
Enrico Compalati
Biljana Cvetkovski
Jane Da Silva
Janet Davies
Danilo Di Bona
Maria V. Dimou
Maria Do Ceu Teixeira
Radoslaw Gawlik
Maximiliano R. Gómez
Maia Gotua
Christos Grigoreas
Ineta Grisle
Maria Antonieta Guzman
Rachel House Tan
Michael Hyland
Despo Ierodiakonou
Aspasia Karavelia
Marta Kisiel
Carlo Lombardi
Cem Meço
Eris Mesonjesi
Florin Mihaltan
Marcin Moniuszko
Robert Naclerio
Sophia Neisinger
Edgar Arturo Perdomo‐Flores
Nhan Pham‐Thi
Emmanuel Prokopakis
Daniela Rivero Yeverino
Giovanni Rolla
Jan Romantowski
Maia Rukhadze
Daiju Sakurai
Laila Salameh
Faradiba Serpa Sarquis
Krzysztof Specjalski
Vesna Tomic‐Spiric
Martina Vachova
Ilgim Vardaloglu Koyuncu
Pakit Vichyanond
Fanny Wai San Ko
Pascal Werminghaus
Vicky Paraskevi Xepapadaki
João A. Fonseca
Abstract (eng)
The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines produced their first edition in 1999, with subsequent revisions in 2008, 2010, 2016 and 2019. A new iteration of ARIA—ARIA 2024–2025—in collaboration with EAACI is currently being developed, focusing on the management of allergic rhinitis. ARIA 2024–2025 follows the GRADE framework and is endorsed by the European Academy of Allergy and Clinical Immunology (EAACI). A set of approaches has been used to develop guideline questions, including surveying key opinion leaders and using artificial intelligence (AI)-based tools to analyse web searches on allergic rhinitis and to generate questions. Each prioritised guideline question is assessed through an Evidence-to-Decision (EtD) framework. EtDs support the systematic and transparent formulation of recommendations, comprising 12 criteria for which the best available evidence should be sought. In the context of ARIA-EAACI 2024–2025, such evidence is derived not only from randomised controlled trials but also—among others—from patient-generated data sources that better reflect the affected individuals' perspectives. Moreover, ARIA-EAACI 2024–2025 incorporates evidence on planetary health. Developed guideline recommendations will support the creation of digitalised decision algorithms and care pathways. This paper describes the methodology used to develop the person-centred, digitally enabled and AI-assisted ARIA-EAACI 2024–2025. Among others, it describes (i) the development and prioritisation of guideline questions, (ii) sources of evidence for EtDs and (iii) the development of digitalised decision algorithms and care pathways.
Keywords (eng)
Allergic RhinitisAsthmaENT (rhinitis, sinusitis, nasal polyps…)guidelines
Type (eng)
Language
[eng]
Persistent identifier
Is in series
Title (eng)
Allergy
Volume
81
Issue
2
ISSN
0105-4538
Issued
2026
Number of pages
27
Publication
Wiley
Version type (eng)
Date issued
2026
Access rights (eng)
License
Rights statement (eng)
© 2025 The Author(s)
- Cite as
Persistent identifier
https://phaidra.vetmeduni.ac.at/o:5351 - Other links and identifiers
- Content
- RightsLicenseRights statement© 2025 The Author(s)
- DetailsResource typeText (PDF)Formatapplication/pdfCreated17.07.2026 07:48:38 UTC
- Usage statistics--
- This object is in collection
- Metadata
- Export formats